# The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer

> **NCT04183478** · PHASE2,PHASE3 · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 600 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** K-001
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT04183478
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-26
- **Primary completion:** 2021-03
- **Final completion:** 2021-03
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2020-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04183478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04183478, "The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04183478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*